TERIFRAC injection is a prescription brand name medicine containing tripartite, a synthetic version of the natural human Parathyroid hormone.  It is used to build new bone mass, increase bone mineral density, and treat severe osteoporosis in men and postmenopausal women who face a high risk of bone fractures. It is a powerful anabolic agent crucial for treating severe osteoporosis and reducing fracture risk. It enhances overall bone mineral density and repairs internal bone geometry and strength. It is specifically prescribed for postmenopausal women , men with high fracture risk, and patient with glucocorticoid –induced osteoporosis .

WHAT IS TERIFRAC INJECTION?

TERIFRAC injection is classified as a recombinant human parathyroid hormone analog used to treat severe osteoporosis . it contains the active ingredient teriparatide , which is a synthetic version of the natural parathyroid hormone (PTH 1_34).

Key classification 

• Drug class: parathyroid hormone analog/Bone formation stimulant .
• Active ingredient: Teriparatide (rHu PTH (1-34)).
• Mechanism of action: Anabolic agent that activates osteoblasts to build new bone mass.
• Role in stimulating new bone formation: unlike most osteoporosis drugs that only stop bone loss. Terifrac acts as an anabolic agent, meaning it actively builds new bone tissue. It restores lost bone micro-architecture, increases bone mineral density (BMD) , and enhances overall strength , particularly in the spine and hip.

WHAT ARE THE MEDICAL USES OF TERIFRAC INJECTION?

Medical uses of TERIFRAC injection are:

1)Postmenopausal osteoporosis

Terifrac injection contains teriparatide, a synthetic parathyroid hormone used to treat severe postmenopausal osteoporosis by stimulating new bone formation. It actively increases bone mineral density, improves bone strength and lowers the risk of fractures. It act as an anabolic agent that turns on bone-forming cells . it is given as a daily shot under the skin usually in the thigh or belly. It is limited to maximum of 24 months over a person’s lifetime.

• Treatment of severe osteoporosis in postmenopausal women

TERIFRAC injection is an anabolic bone-building treatment prescribed for severe osteoporosis in postmenopausal women at high risk for fractures. It works by actively stimulating new bone formation and increasing bone mineral density rather than just slowing down bone loss. It act as an anabolic agent , directly revving up osteoblast cells to build new skeletal mass and improve overall bone strength .

• Reduction of vertebral and non-vertebral fracture risk

TERIFRAC injection reduces the risk of vertebral fractures by 65% to 66% and non-vertebral fractures by 37% to 53% compared to placebo. It works as a bone –building anabolic agent to treat severe osteoporosis .

• Vertebral fracture risk

Decreased significantly by roughly 65%-66% in clinical evaluations.

• Non-vertebral fracture risk

Reduced by 37% for all non –vertebral sites, and up to 53% -56% for low-energy fragility fractures.

2)Osteoporosis in men

TERIFRAC injection contains teriparatide, a synthetic parathyroid hormone used to treat severe osteoporosis in men by building new bone, increasing bone mineral density , and lowering fracture risk. It is typically prescribed for primary, hypogondal or steroid-induced osteoporosis in male patients.

• Treatment of men at high risk of fractures

TERIFAC injection contains teriparatide , a synthetic parathyroid hormone used to treat men with primary , hypogonadal or glucocorticoid –induced osteoporosis who face a high risk of bone fractures . it actively builds new bone, increases bone mineral density and lowers the chance of broken bones .

• Improvement in bone mineral density

TERIFRAC injection improves bone mineral density by using teriparatide, a synthetic parathyroid hormone that actively builds new bone tissue, stimulates bone-forming cells, and strengthens the skeleton. It targets osteoblast , which are the main cells responsible for creating new bone . it also encourages direct bone formation on inactive and active areas of the skeleton . it also raises overall bone density to lower the chance of breaks in the spine and hip .

3)Glucocorticoid –induced osteoporosis

TERIFRAC Injection is an anabolic (bone-building) therapy used to treat glucocorticoid –induced osteoporosis in patients at high risk for bone fractures . it actively stimulates new bone formation to reverse steroid –induced bone loss. The standard amount is 20 mcg given once a day . the treatment is typically limited to a maximum of 24 months over a patients lifetime, unless fracture risk remains very high .

• Prevention and treatment of osteoporosis caused by long-term corticosteroid therapy

TERIFRAC injection medication used to treat glucocorticoid –induced osteoporosis in men and women at high risk of fractures . long-term corticosteroid therapy suppresses bone formation ,teriparatide counteracts this by actively stimulating new bone creation. It activates bone-forming cells that corticosteroids suppress ,directly building new bone tissue. It increases bone mineral density in the spine and hip, lowering fracture risk.

• Reduction of fracture risk in high –risk patients

TERIFRAC Injection , containing teriparatide, actively builds new bone mineral density , significantly lowering the chance of broken bones in high-risk patients with severe osteoporosis or glucocorticod use. Unlike regular drugs that only stops bone loss , it directly stimulate  bone-forming cells to create fresh bone tissue. It also repairs bone micro architecture , making the spine and hip much stronger against fracture breaks.

HOW TERIFRAC INJECTION WORKS?

TERIFRAC injection works by acting as a synthetic version of the human parathyroid hormone , stimulating new bone formation , increasing bone mineral density, and improving bone strength .

It works by the following ways:

• Mechanism of action of Teriparatide

Teriparatide in Terifrac injection works as an anabolic agent by intermittently stimulating osteoblasts, enhancing calcium reabsorption and activating bone formation. It binds to the PTH1 receptor ,a G protein –coupled receptor .Daily low dose injections provide brief , intermittent exposure that preferentially activates bone-forming cells much more than bone-resorbing cells. It increases creation of new bone matrix on both cancellous and cortical bone surfaces , improving overall bone mineral density and strength .

• Stimulation of osteoblast activity

Intermittent daily doses of Terifrac injection stimulate bone-building osteoblasts much more than bone-clearing osteoclasts. This daily pulse briefly increases osteoclasts breakdown markers later on, but it leads to net gain in new bone growth .

• Promotion of new bone formation

Terifrac injection promotes new bone formation by using teriparatide , a synthetic form of parathyroid hormone, which activates osteoblast cells to rebuild bone mass and strengthen . its direct activation increases bone mineral density and improves the structural architecture of the skeleton .

• Improvement in bone strength and bone mineral density

Terifrac injection improves bone strength and bone mineral density by supplying a synthetic form of parathyroid hormone that activates bone-forming cells ,stimulates new tissue growth and repairs skeletal architecture . it is used to treat severe osteoporosis in men and postmenopausal women are at high risk of fractures according to 1 mg.

CONCLUSION

TERIFRAC injection effectively builds stronger bones by acting as an anabolic bone-mineral density and significantly reducing fracture risks. It stimulates osteoblast activity to form new bone mineral density and significantly reducing fracture risks. It stimulates osteoblast activity to form new bone faster than it is broken down .

FREQUENTLY ASKED QUESTIONS (FAQs)

QUESTION: WHAT IS TERIFRAC INJECTION USED FOR?

TERIFRAC injection is used to treat severe bone –weakening conditions like postmenopausal osteoporosis, male osteoporosis and steroid –induced bone loss. It contains teriparatide, a synthetic parathyroid hormone that builds new bone and lowers fracture risks.

QUESTION: HOW DOES TERIPARATIDE HELP BUILD NEW BONE  ?

TERAPARATIDE helps one bones by acting as an anabolic agent that stimulates bone formation ,increases bone mineral density and significantly reduces fracture risks. Unlike most treatments that only slow down bone loss, it actively stimulate the cells that build bone when given in a once –daily intermittent dose.

QUESTION: HOW LONG CAN TERIFRAC INJECTION BE USED?

TERIFRAC injection is typically used for a maximum period of 2 years in a patient lifetime . this limit helps lower the chance of unwanted side effects .

REFRENCES:

1)https://www.1mg.com/drugs/terifrac-injection-166996?wpsrc=Google+Organic+Search

 2)https://www.drugs.com/medical-answers/how-useful-and-side-effects-of-injection-terifrac-416209/